Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)

Denis L. Fontes Jardim; Maria Schwaederle; Maria Wei; J. Jack Lee; David S. Hong; Alexander M. Eggermont; Richard L. Schilsky; John Mendelsohn; Vladimir Lazar; Razelle Kurzrock

doi:10.1093/jnci/djv423

Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)

Denis L. Fontes Jardim, Maria Schwaederle, Maria Wei, J. Jack Lee, David S. Hong, Alexander M. Eggermont, Richard L. Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	djv423
Journal	Journal of the National Cancer Institute
Volume	108
Issue number	2
DOIs	https://doi.org/10.1093/jnci/djv423
State	Published - Feb 1 2016

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/djv423

Cite this

Fontes Jardim, D. L., Schwaederle, M., Wei, M., Lee, J. J., Hong, D. S., Eggermont, A. M., Schilsky, R. L., Mendelsohn, J., Lazar, V., & Kurzrock, R. (2016). Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253). Journal of the National Cancer Institute, 108(2), Article djv423. https://doi.org/10.1093/jnci/djv423

Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253). / Fontes Jardim, Denis L.; Schwaederle, Maria; Wei, Maria et al.
In: Journal of the National Cancer Institute, Vol. 108, No. 2, djv423, 01.02.2016.

Research output: Contribution to journal › Comment/debate › peer-review

Fontes Jardim, DL, Schwaederle, M, Wei, M, Lee, JJ , Hong, DS, Eggermont, AM, Schilsky, RL, Mendelsohn, J, Lazar, V & Kurzrock, R 2016, 'Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)', Journal of the National Cancer Institute, vol. 108, no. 2, djv423. https://doi.org/10.1093/jnci/djv423

Fontes Jardim DL, Schwaederle M, Wei M, Lee JJ , Hong DS, Eggermont AM et al. Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253). Journal of the National Cancer Institute. 2016 Feb 1;108(2):djv423. doi: 10.1093/jnci/djv423

@article{11a475fba6ec4453bcbbf9c79d13c40e,

title = "Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)",

author = "{Fontes Jardim}, {Denis L.} and Maria Schwaederle and Maria Wei and Lee, {J. Jack} and Hong, {David S.} and Eggermont, {Alexander M.} and Schilsky, {Richard L.} and John Mendelsohn and Vladimir Lazar and Razelle Kurzrock",

year = "2016",

month = feb,

day = "1",

doi = "10.1093/jnci/djv423",

language = "English (US)",

volume = "108",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)

AU - Fontes Jardim, Denis L.

AU - Schwaederle, Maria

AU - Wei, Maria

AU - Lee, J. Jack

AU - Hong, David S.

AU - Eggermont, Alexander M.

AU - Schilsky, Richard L.

AU - Mendelsohn, John

AU - Lazar, Vladimir

AU - Kurzrock, Razelle

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84962491924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962491924&partnerID=8YFLogxK

U2 - 10.1093/jnci/djv423

DO - 10.1093/jnci/djv423

M3 - Comment/debate

C2 - 26727926

AN - SCOPUS:84962491924

SN - 0027-8874

VL - 108

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 2

M1 - djv423

ER -

Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this